Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: A randomized trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Benzenesulfonates
  • Carcinoma, Hepatocellular
  • Doxorubicin
  • Liver Neoplasms
  • Pyridines

abstract

  • clinicaltrials.gov Identifier: NCT00108953.

publication date

  • November 17, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.2010.1672

PubMed ID

  • 21081728

Additional Document Info

start page

  • 2154

end page

  • 60

volume

  • 304

number

  • 19